26
Opioid Analgesics Mr. RVS Chaitanya Koppala Lovely professional university,

opioid anlagesic and its antagonist

Embed Size (px)

Citation preview

Page 1: opioid anlagesic and its antagonist

Opioid Analgesics

Mr. RVS Chaitanya KoppalaLovely professional university, Punjab

Page 2: opioid anlagesic and its antagonist

Opioid Analgesics (against algesia) – some important

terms• Analgesics: Are the Drugs which selectively relieves pain by

acting in the CNS or on peripheral pain mechanisms, without significantly altering the consciousness – Opioids and NSAIDS

• Opioids: Any drug which binds to the opioid receptors (Pharmacologically related) in the CNS and antagonized by Naloxone . They may be – Natural, Synthetic and semi-synthetic

• Opiates: Drugs derived from opium – Natural or semi-synthetic

• Narcotics: Drugs derived from opium or opium like compounds, with potent analgesic effects associated with significant alteration of mood and behavior, and with the potential for dependence and tolerance following repeated administration.

Page 3: opioid anlagesic and its antagonist

Opioids - Opium• A dark brown, resinous material

obtained from poppy (Papaver somniferum) Capsules.

OPIUM

PHENANTHRENE•Morphine 9-14%•Codeine 0.5-2%•Thebaine 0.2-1%

BENZYLISOQUINOLINE•Papaverine 0.8-1%•Noscapine 3-10%•Narcine 0.2-0.4%

Page 4: opioid anlagesic and its antagonist

Poppy Plant - image

Page 5: opioid anlagesic and its antagonist

MORPHINE (Pharmacological actions) - CNS

• Analgesia:• Strong analgesic• Visceral pain is relieved better than somatic

pain• Degree of analgesia increases with dose• Nociceptive pain is better relieved than

Neuretic pain• Associated reactions to pain are also relieved

– apprehension, fear and autonomic effects• Tolerance to pain is better

Page 6: opioid anlagesic and its antagonist

MORPHINE – Analgesia action

• Two components – spinal and supraspinal

• Inhibits release of excitatory transmitters from primary afferents – at Substantia gelatinosa of dorsal horn

• Exerted through Interneurones – gating of pain• At supraspinal level in cortex, meidbrain and

medulla - alter processing and interpretation and send inhibitory impulses through descending pthway

Page 7: opioid anlagesic and its antagonist

Pharmacological actions of Morphine (CNS) –

contd.• Sedation:

– Drowsiness and indifference to surroundings– Inability to concentrate and extravagant imagination –

colorful day dream– Apparent excitement– Larger doses produce sleep – EEG resembles normal sleep

• Mood effects:– In Normal persons calming effect, mental clouding, feeling

of detachment, lack of initiative etc. - unpleasant in absence of pain

– Sometimes DYSHORIA– But in persons with pain & addicts sense of wellbeing,

pleasurable floating feelings – kick– EUPHORIA

Page 8: opioid anlagesic and its antagonist

Pharmacological actions of Morphine (CNS) –

contd.• Depression:

1. Respiratory centre depression – Both rate and depth of respiration are diminished• Dangerous in Head

injury and asthmatics2. Cough Centre –

Depressed3. Temperature regulating

centre – depressed4. Vasomotor centre – high

doses cause fall in BP

• Stimulation:1. CTZ – sensitize CTZ to

vestibular and other impulses

2. Edinger Westphal Nucleus – miosis

3. Vagal centre – Bradycardia

4. Hippocampal cells – convulsions (inhibition of GABA release)

Page 9: opioid anlagesic and its antagonist

Pharmacological actions of Morphine –

contd.• Neuro-endocrine:

• GnRH and CRH are inhibited – FSH, LH and ACTH levels are lowered – only short term – tolerance develops

• Decrease in levels of Sex hormone and corticosteroids, but no infertility

• Increases ADH release – oliguria• CVS: NO DIRECT EFFECT ON HEART

• Vasodilatation – histamine release, depression of vasomotor centre and directly on blood vessels decreasing the tone

• Cardiac work reduction due to consistent vasodilatation

Page 10: opioid anlagesic and its antagonist

Pharmacological actions of Morphine –

contd.• GIT: CONSTIPATION

• Due to direct action on intestine reducing propulsive movement, spasm of sphincters, decrease in all GIT secretions

• Smooth Muscles:• Billiary Tract: Billiary colic – closure of sph. Of

Oddi• Bladder: Urinary urgency but difficulty• Bronchi - Bronchospasm

Page 11: opioid anlagesic and its antagonist

Morphine - Pharmacokinetics

• Absorption and Distribution:• Variable orally (usually not given orally – 1st pass metabolism,

given IM or IV)• Widely distributed – liver, spleen, kidney etc.• Enters Brain slowly• Readily crosses placental barrier – dependence in fetus

• Metaboloism:• In Liver by glucoronidation – water soluble metabolites • Morphine-6- Glucoronide – analgesic – in renal failure prolong

analgesia• Morphine-3-glucoronide – No analgesia – neuroexcitatory

• Excretion: • Via Urine, Plasma t1/2 = 2-3 Hrs• Action lasts for 4-6 Hrs• Completely eliminated in 24 Hrs

• Preparation: 10, 15, and 20 mg. (IV: 2 – 10 mg)

Page 12: opioid anlagesic and its antagonist

Morphine – Adverse Effects

1. Respiratory Depression: Infant and Old2. Vomiting3. Sedation, Mental Clouding – sometimes dysphoria4. Hypotensive effect5. Rise in Intracranial Pressure6. Apnoea: Newborn7. Urinary retention8. Idiosyncrasy and allergy9. Acute Morphine Poisoning: occurs if >50 mg (Lethal dose –

250 mg), Gastric lavage with KMNO4, Specific antidote: Naloxone: 0.4 to 0.8 mg IV repeatedly in 2-3 minutes till respiration picks up

10. Tolerance and dependence

Page 13: opioid anlagesic and its antagonist

Morphine – Therapeutic uses

• Analgesic:1. Long Bone Fracture2. Myocardial Infarction3. Terminal stages of cancer4. Burn patients5. Postoperative patients6. Visceral pains – pulmonary embolism, pleurisy,

acute pericarditis7. Biliary colic and renal colic8. Obstetric analgesia9. Segmental analgesia

Page 14: opioid anlagesic and its antagonist

Morphine – Other Therapeutic uses

• Preanaesthetic Medication• Balanced anaesthesia and surgical

analgesia• Acute Left ventricular failure – Cardiac

asthma• Cough – not used but Codeine is used• Diarrhoea – colostomy - Loperamide,

Diphenoxylate

Page 15: opioid anlagesic and its antagonist

Morphine - Contraindications

1. Two Extremes of Age2. Bronchial asthma 3. Respiratory insufficiency - empysema4. Head Injury5. Shock – Hypotension6. Undiagnosed acute abdomen7. BHP8. Renal Failure, Liver diseases and hypothyrodism9. Unstable personalities

Page 16: opioid anlagesic and its antagonist

Opioids - Classification1. Natural Opium Alkaloids: Morphine and Codeine2. Semi-synthetic: Diacetylmorphine (Heroin) and

Pholcodeine3. Synthetic Opioids:

• Phenylpiperidines: • Pethidine (Mepiridine) and its congeners –

Diphenoxylate and Loperamide• Fentanyl and its congeners – sufentanil, remifentanil

and alfentanil• Phenyl-heptylmines: Methadone and congeners like

Propoxyphene and Dextropropoxyphene• Benzomorphans: Pentazocine• Morphinan compounds and congeners: Levorphanol and

Butorphanol

Page 17: opioid anlagesic and its antagonist

Pethidine • Morphine Vs Pethidine:

– 1/10th as potent as Morphine, but Efficacy is similar– Produces as much sedation, euphoria and

respiratory depression in equianalgesic dose and similar abuse potential

– Less spasmodic action in smooth muscles – less miosis, constipation and urinary retention

– Rapid but short duration of action (2-3 Hrs)– Vagolytic effect - Tachycardia– Devoid of antitussive action– Less histamine release – safer in asthmatics– Better oral absorption

Page 18: opioid anlagesic and its antagonist

Pethidine – contd.• Pharmacokinetics

– Well absorbed orally, bioavailability 50%– Effects appear in 10-15 min. after oral

absorption– On parenteral administration action lasts

for 2-3 Hrs– Metabolized in liver – mepiridinic acid and

norpethidine– Norpethidine accumulates on chronic use– Excreted in urine

Page 19: opioid anlagesic and its antagonist

Pethidine – contd.• Adverse Effects:

• Similar to Morphine• Atropine like effects – dry mouth, blurred vision,

tachycardia• Overdose – tremors, mydriasis, delirium and

convulsion due to norpethidine accumulation• Uses:

• Analgesic as substitute of Morphine• Ptreanaesthetic medication• As analgesic during labour – less fetal respiratory

depression• Dose 50-100 mg IM/SC, oral – 50-100 mg tabs.

Page 20: opioid anlagesic and its antagonist

Opioid Receptors• Mainly 3 (three) types of receptors – μ (mu), κ (kappa)

and δ (delta)• Subtypes: μ1, μ2, κ1, κ2, κ3, δ1 and δ2 • Location: Peripheral Nerve endings, SG in spinal chord,

Periaqueductal gray (PAG) in midbrain and Brain stem (medulla, hypothalumus and also amygdala

• Opioids are – agonists, partial agonist or competitive antagonists of these receptors

• Overall effect depends on nature of interaction and affinity to these

• Morphine is agonist of all but affinity is higher for mu

Page 21: opioid anlagesic and its antagonist

μ receptor κ receptor δ receptorLocation μ1 – supraspinal

μ2 - spinalκ1 – spinalκ3 -supraspinal

Spinalsupraspinal

Effects AnalgesiaRespiratory depressionSedationEuphoriaMiosisPhysical dependenceLoss of GI motility

Spinal analgesiaDysphoriaSedationPsychomimeticPhysical dependence (nalorphine type)

Spinal analgesiaAffective behaviour (Supraspinal) Respiratory depressionReduced GI motility

Agonists Morphine, Codeine, Fentanyl and pentazocine weakly

Pentazocine

Effects of Different Opioid Receptor Stimulation:

Page 22: opioid anlagesic and its antagonist

Opioid Receptors – Intracellular mechanism

• All are G-protein coupled receptors• Located on prejunctional neurones• Inhibits release of transmitters – NA, DA, 5-HT,

GABA and Glutamate• Activation reduces intracellular cAMP

formation - Opening of K+ channel via μ and δ. and supression of N type of Ca++ channels

• Ultimately Hyperpolarization and reduced intracellular Ca++ Reduced Neurotransmitter release

Page 23: opioid anlagesic and its antagonist

Opioid Antagonists1. Pure antagonists: Naloxone, Naltrexone and

Nalmefene• Affinity for all receptors (μ, δ and κ)• Can displace opioids bound to α-receptors• No action on Normal person but reverses poisoning and

withdrawal symptoms in addicts2. Mixed Agonist-antagonists: Nalorphine,

Pentazocine, Butorphanol and Nalbuphine3. Partial/weak μ agonist and κ antagonist:

Buprenorphine

Page 24: opioid anlagesic and its antagonist

Nalorphine• Not used anymore• Previously used as Opioid antagonist• But, antagonism is restricted to μ-

receptor only and agonist of κ-receptor

• Drawbacks - dysphoria and psychomimetic effects

Page 25: opioid anlagesic and its antagonist

Pentazocine• Weak α-receptor antagonist, but agonist of κ-receptor• One of the commonly used agents, given orally and IM• Low abuse liability• Pharmacokinetics:

– High 1st pass metabolism but effective orally– Half life = 3-4 Hrs– Metabolized in liver by glucoronide conjugation– Dose: orally 50-100 mg and parenterally 30-60 mg IM

• Uses:Moderately severe pain in Injury, Burns, Fracture Trauma, Cancer and Orthopaedic manuevers

(Fortwin, Fortagesic)

Page 26: opioid anlagesic and its antagonist

Pentazocine Vs Morphine

• Spinal analgesia via kappa receptor• Dose is 30 mg Vs 10 mg and low ceiling effect• Sedation and Respiratory depression at lower doses• Tachycardia and rise in BP – dangerous in MI• Lesser smooth muscle spasms• Vomiting and other side effects are less• Subjective effects – lower ceiling (psycomimetic effects)• Tolerance develops on repeated use, but lesser than

Morphine• Withdrawal symptoms – both Morphine and Nalorphine like• Good analgesic in subjects not exposed to Morphine• Precipitate withdrawal – in Morphine addicts